From Molecules to Medicine: New Horizons in Vascular Biology and Thrombosis (Part II)

 

Notes

^* The author was president of the 52^nd GTH-Congress in Wiesbaden, Germany, February 20–23, 2008.

• References

• 1 Gachet C. P2 receptors, platelet function and pharmacological implications. Thromb Haemost 2008; 99: 466-472.
• 2 Clemetson K, Clemetson J. Platelet GPIb complex as a target for anti-thrombotic drug development. Thromb Haemost 2008; 99: 473-479.
• 3 Langer H, Gawaz M. Platelet-vessel wall interactions in atherosclerotic disease. Thromb Haemost 2008; 99: 480-486.
• 4 May AE, Geisler T, Gawaz M. Individualized antithrombotic therapy in high risk patients after coronary stenting. Thromb Haemost 2008; 99: 487-493.
• 5 Wygrecka M, Jablonska E, Guenther A. et al. Current view on alveolar coagulation and fibrinolysis in acute inflammatory and chronic interstitial lung diseases. Thromb Haemost 2008; 99: 494-501.
• 6 Alessi MC, Juhan-Vague I. Metabolic syndrome, haemostasis and thrombosis. Thromb Haemost. 2008 99. to be published in the April issue.